tradingkey.logo
tradingkey.logo
Search

Xtant Medical Holdings Inc

XTNT
Add to Watchlist
0.456USD
-0.014-2.91%
Close 05/15, 16:00ETQuotes delayed by 15 min
63.95MMarket Cap
34.64P/E TTM

Xtant Medical Holdings Inc

0.456
-0.014-2.91%

More Details of Xtant Medical Holdings Inc Company

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.

Xtant Medical Holdings Inc Info

Ticker SymbolXTNT
Company nameXtant Medical Holdings Inc
IPO dateJun 30, 2010
CEOBrowne (Sean E)
Number of employees217
Security typeOrdinary Share
Fiscal year-endJun 30
Address664 Cruiser Lane
CityBELGRADE
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code59714
Phone14063880480
Websitehttps://xtantmedical.com/
Ticker SymbolXTNT
IPO dateJun 30, 2010
CEOBrowne (Sean E)

Company Executives of Xtant Medical Holdings Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
6.96M
-7.95%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
755.89K
-20.93%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
370.27K
-53.11%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
--
Mr. Mark A. Schallenberger
Mr. Mark A. Schallenberger
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jonn R. Beeson
Mr. Jonn R. Beeson
Independent Director
Independent Director
--
--
Ms. Lori D. Mitchell-Keller
Ms. Lori D. Mitchell-Keller
Independent Director
Independent Director
--
--
Mr. Tyler P. Lipschultz
Mr. Tyler P. Lipschultz
Director
Director
--
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Director
Independent Director
--
--
Mr. Sean E. Browne
Mr. Sean E. Browne
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
6.96M
-7.95%
Mr. John K. Bakewell
Mr. John K. Bakewell
Independent Director
Independent Director
755.89K
-20.93%
Mr. Scott C. Neils
Mr. Scott C. Neils
Chief Financial Officer
Chief Financial Officer
370.27K
-53.11%
Mr. Abhinav (Abi) Jain
Mr. Abhinav (Abi) Jain
Director
Director
158.23K
--
Mr. Mark A. Schallenberger
Mr. Mark A. Schallenberger
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jonn R. Beeson
Mr. Jonn R. Beeson
Independent Director
Independent Director
--
--

Revenue Breakdown

Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Orthobiologics
72.89M
54.43%
Spinal implant
42.31M
31.59%
License revenue
18.72M
13.98%
By RegionUSD
Name
Revenue
Proportion
United States
122.45M
91.43%
Rest of World
11.48M
8.57%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Orthobiologics
72.89M
54.43%
Spinal implant
42.31M
31.59%
License revenue
18.72M
13.98%

Shareholding Stats

Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Nantahala Capital Management, LLC
48.83%
Lytton (Laurence W)
5.50%
Vizirgianakis (Stavros G)
4.97%
AWM Investment Company, Inc.
4.71%
Vanguard Capital Management, LLC
1.44%
Other
34.56%
Shareholders
Shareholders
Proportion
Nantahala Capital Management, LLC
48.83%
Lytton (Laurence W)
5.50%
Vizirgianakis (Stavros G)
4.97%
AWM Investment Company, Inc.
4.71%
Vanguard Capital Management, LLC
1.44%
Other
34.56%
Shareholder Types
Shareholders
Proportion
Hedge Fund
49.89%
Individual Investor
13.86%
Investment Advisor/Hedge Fund
5.61%
Investment Advisor
2.41%
Research Firm
0.03%
Other
28.20%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
41
80.10M
114.61%
--
2026Q1
63
83.43M
59.56%
-78.98M
2025Q4
60
79.98M
57.13%
-82.26M
2025Q3
58
80.07M
57.19%
-75.11M
2025Q2
66
93.42M
67.06%
-16.04M
2025Q1
66
107.33M
77.15%
-2.25M
2024Q4
65
107.45M
77.30%
-1.32M
2024Q3
60
109.08M
78.63%
+8.43M
2024Q2
61
99.68M
76.50%
-1.69M
2024Q1
63
100.56M
77.45%
+777.79K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Nantahala Capital Management, LLC
68.39M
48.85%
--
--
Dec 31, 2025
Lytton (Laurence W)
7.70M
5.5%
-1.76M
-18.61%
Dec 31, 2025
Vizirgianakis (Stavros G)
7.52M
5.37%
+553.80K
+7.95%
Nov 15, 2025
AWM Investment Company, Inc.
6.59M
4.71%
--
--
Dec 31, 2025
Browne (Sean E.)
1.94M
1.39%
+394.94K
+25.57%
Nov 15, 2025
Beeson (Jonn R.)
1.53M
1.09%
+158.23K
+11.51%
Nov 15, 2025
Renaissance Technologies LLC
919.86K
0.66%
+205.94K
+28.85%
Dec 31, 2025
Bakewell (John K)
914.12K
0.65%
+158.23K
+20.93%
Nov 15, 2025
Geode Capital Management, L.L.C.
491.95K
0.35%
--
--
Dec 31, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI